New Milford, CT, United States of America

Kollol Pal


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kollol Pal: Innovator in Pharmaceutical Research

Introduction

Kollol Pal is a distinguished inventor based in New Milford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of HIV and related disorders. With a total of 4 patents to his name, Pal's work is recognized for its potential impact on public health.

Latest Patents

Pal's latest patents include innovative compounds such as pyridobenzo- and pyridiothieno-diazepines. These novel pyrido[2,3-b][1,5]benzodiazepines are disclosed as useful in the treatment of AIDS, ARC, and related disorders associated with HIV infection. Another significant patent involves pyrido[2,3-b][1,4]benzodiazepines, which also target similar health issues. These compounds represent a promising avenue for therapeutic intervention in the fight against HIV.

Career Highlights

Kollol Pal is currently employed at Boehringer Ingelheim Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing effective treatments for serious health conditions.

Collaborations

Pal has collaborated with notable colleagues in the field, including Julian Adams and Karl D Hargrave. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kollol Pal's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the fight against HIV. His work not only showcases his expertise but also reflects the potential for scientific advancements to improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…